BRTX Stock Analysis: Buy, Sell, or Hold?
BRTX - BioRestorative Therapies, Inc. Common Stock (NV)
$0.21
0.01 (6.11%)
▲
5d:
-21.23%
30d:
-46.94%
90d:
-13.22%
WAIT
LOW Confidence
Analysis Updated: Aug 4, 2026 12:00 AM ET
Earnings: Aug 11, 2026
5d
Get Alerted When BRTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BRTX is down 21.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BRTX is down 21.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BRTX is currently trading at $0.21, which is considered oversold relative to its 30-day fair value range of $0.28 to $0.39.
Technical Outlook: Technically, BRTX is in a downtrend. Immediate support is located at $0.19, while resistance sits at $0.35. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+3709.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BRTX is in a downtrend. Immediate support is located at $0.19, while resistance sits at $0.35. The stock is showing strong short-term momentum, up 6.1% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $8.00 (+3709.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.28 -
$0.39
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.1%)
- BULLISH: Trading 3709.5% below Wall St target ($8.00)
- WARNING: Recommendation downgraded due to -21.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.28 -
$0.39
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.19
Resistance Level
$0.35
Current Trend
Downtrend
Technical data as of
Aug 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.40
Wall Street Target
$8.00
(+3709.5%)
Revenue Growth (YoY)
-7.3%
Share & Embed Analysis
Last updated: August 04, 2026 8:41 PM ET
Data refreshes hourly during market hours. Next update: 9:41 PM
Data refreshes hourly during market hours. Next update: 9:41 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BRTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 47 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$834 | 51 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$267 | 58 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 46 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
BUY
20 analysts |
$33 | 55 HOLD |
